Career records & work history
Real Estate Brokers
Chris Tran
Specialties:
Buyer's Agent, Listing Agent
Work:
Chris Anh Tran, 552695 S Decatur Blvd STE 500, Las Vegas, NV 89102
Chris Tran Phones & Addresses
2695 S Decatur Blvd STE 500, Las Vegas, NV 89102 702-5246307
5001 Monte Bella Pl, Franklin, TN 37067
Santa Monica, CA
Sherman Oaks, CA
Work
Company:
[email protected]
Address:
2944 Garona Drive
Phones:
626-3742500 (Office)
Mentions for Chris Anh Tran
Publications & IP owners
Us Patents
Diarylthiohydantoin Compounds
US Patent:
8110594, Feb 7, 2012
Filed:
Mar 29, 2007
Appl. No.:
11/730168
Inventors:
Michael E. Jung - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166
C07D 233/86
C07D 233/86
US Classification:
514391, 5483211, 5483014
Abstract:
The present invention relates to diarylthiohydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-Associated Diseases
US Patent:
8445507, May 21, 2013
Filed:
Mar 27, 2007
Appl. No.:
12/294881
Inventors:
Michael E. Jung - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4439
C07D 213/60
C07D 213/60
US Classification:
514278, 514341, 546 15, 5462741
Abstract:
A hydantoin compound useful for the prevention or treatment of hyperproliferative diseases or disorders.
Diarylthiohydantoin Compounds
US Patent:
8648105, Feb 11, 2014
Filed:
Dec 21, 2011
Appl. No.:
13/333543
Inventors:
Michael E. Jung - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166
C07D 233/86
C07D 233/86
US Classification:
514389, 5483014, 5483171
Abstract:
The present invention relates to diarylthiohydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2009011, Apr 30, 2009
Filed:
Oct 24, 2008
Appl. No.:
12/257743
Inventors:
MICHAEL E. JUNG - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4184
C07D 233/86
C07D 403/10
C07D 235/02
A61K 31/4166
C07D 233/86
C07D 403/10
C07D 235/02
A61K 31/4166
US Classification:
514391, 5483211, 5483144, 5483014
Abstract:
The present invention relates to diarylhydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-Associated Diseases
US Patent:
2013007, Mar 21, 2013
Filed:
Sep 13, 2012
Appl. No.:
13/615085
Inventors:
Michael E. Jung - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 31/4439
A61P 35/00
C07D 401/04
A61P 35/00
C07D 401/04
US Classification:
514278, 546 15
Abstract:
Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.
Diarylhydantoin Compounds
US Patent:
2023010, Apr 13, 2023
Filed:
Jul 13, 2022
Appl. No.:
17/863841
Inventors:
- Oakland CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 235/02
C07D 233/70
C07D 233/74
C07D 471/10
C07D 233/86
C07D 233/70
C07D 233/74
C07D 471/10
C07D 233/86
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2021023, Aug 5, 2021
Filed:
Nov 3, 2020
Appl. No.:
17/088148
Inventors:
- Oakland CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 235/02
C07D 233/70
C07D 233/74
C07D 471/10
C07D 233/86
C07D 233/70
C07D 233/74
C07D 471/10
C07D 233/86
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2020007, Mar 12, 2020
Filed:
Jul 17, 2019
Appl. No.:
16/514354
Inventors:
- Oakland CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 235/02
C07D 233/86
C07D 471/10
C07D 233/74
C07D 233/70
C07D 233/86
C07D 471/10
C07D 233/74
C07D 233/70
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.